INTRODUCTION
Voltage-gated calcium channel genes encode a large family of channel proteins (a1 subunits) that play critical roles in neuronal excitability, transmitter release, muscle contractility, and gene expression (Catterall, 2011) . Genetic defects of these channels have been implicated in a variety of neurological, cardiac, and skeletal muscle disorders (Cain and Snutch, 2011) . Diverse mutations in the a1A subunit, CACNA1A gene, causing either loss or gain of P/Q-type channel function, have been associated with dominantly inherited conditions of migraine, epilepsy, and episodic and progressive ataxia (Rajakulendran et al., 2012) . The recognition that spinocerebellar ataxia type 6 (SCA6) is due to expansion of a polyglutamine (polyQ) tract encoded by a newly identified 47 th exon in CACNA1A, from a normal range of Q4-Q17 to a pathological range of Q19-Q33, added further complexity to modeling both channel function and disease pathogenesis (Zhuchenko et al., 1997) . Attempts to attribute SCA6 to a disturbance in P/Q-type channel function associated with the expanded polyQ in the a1A subunit in heterologous expression systems have led to contradictory results, whereas two knockin studies showed no effect of expanded polyQ tracts on P/Q channel gating (Saegusa et al., 2007; Watase et al., 2008) . Several laboratories have shown that the C terminus of the a1A subunit (a1ACT), which contains the polyQ tract, is present as a stable fragment in cultured cells or cerebellar tissues (Ishiguro et al., 2010; Kordasiewicz et al., 2006; Kubodera et al., 2003; Marquè ze-Pouey et al., 2008; Scott et al., 1998) and enriched in cerebellar nuclei, based on nuclear localization signals in the a1ACT sequence (Kordasiewicz et al., 2006) . This finding is similar to that of the C-terminal fragment of the L-type subunit that is translocated to the nucleus and functions as a transcription factor (Gomez-Ospina et al., 2006) . Finally, the a1ACT fragment bearing SCA6-expanded polyQs is toxic to cultured cells and primary neurons (Ishiguro et al., 2010; Kordasiewicz et al., 2006; Kubodera et al., 2003; Marquè ze-Pouey et al., 2008) .
Here, we explored the origin and function of the a1ACT polypeptide in physiology and disease. We demonstrate that a1ACT is generated from the full-length a1A transcript by means of a cellular internal ribosomal entry site (IRES) located within the a1A messenger RNA (mRNA), i.e., that the CACNA1A gene is bicistronic. The a1ACT protein containing the normal polyQ tract is a transcription factor that binds and enhances expression of several Purkinje cell (PC)-expressed genes, promotes neurite outgrowth, and partially rescues the CACNA1A knockout phenotype. a1ACT with expanded polyQ has altered function, reduces viability of cells in vitro, and causes gait impairment and cerebellar cortical atrophy in vivo. We identify a truly bicistronic, dual-function cellular gene encoding two proteins with completely distinct functions: in this case, an ion channel and a transcription factor. This gene expression strategy demonstrates a role for an IRES in coordinating gene expression as well as a potential therapeutic target for disease-modifying therapy.
RESULTS
Identification of the C-Terminal Fragment of the CACNA1A-Encoded a1A Subunit To identify the N-terminal sequence of the a1ACT fragment, we tagged the full-length human a1A subunit complementary DNA (cDNA) bearing normal polyQ (Q11), a1A WT , at its 3 0 end with a 3xFLAG epitope and established HEK293 cell lines stably expressing this $220 kDa a1A-FLAG fusion protein. The cell line grew normally and stably expressed the 75 kDa a1ACT-FLAG fusion protein. We affinity purified a1ACT-FLAG from the whole-cell lysate in a two-step procedure. Peak elution fractions ( Figure 1A ) collected from anion exchange chromatography (HiTrap DEAE FF) were subjected to affinity purification using anti-FLAG M2 magnetic beads. The isolated a1ACT fragment protein was seen as a unique 75 kDa band (arrowhead) above the heavy-chain immunoglobulin G (IgG) band on a Coomassie-stained SDS-PAGE gel (Figures 1B and 1C) . Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis of in-gel digest protein (The Rockefeller University Protein Resource Center) revealed that the amino acid sequence of N terminus of a1ACT fragment was Met Ile Met Glu Tyr (amino acids 1,960-1,964, nucleotides 6,114-6,128, GenBank accession numbers 187828892 and NM_001127222) ( Figure 1D ; Figure S1 available online). This sequence, which begins within the IQ-like domain of the full-length a1A subunit and does not overlap with any known protease cleavage site, is a highly homologous sequence in all vertebrate species (Wilkins et al., 1999) .
To investigate the origin of the a1ACT protein fragment, we generated a series of constructs bearing different mutations of the a1A cDNA, as defined in Figure 1E , and transfected them into HEK293 cells. Deletion of 534 bps (a1Adel534bp) abolished the a1ACT fragment expression without affecting the expression of the full-length a1A subunit ( Figure 1H ), whereas other mutations of a1A failed to do so ( Figures 1E-1H ). This indicates that the 534 bp fragment upstream of the a1ACT start site in the a1A cDNA contains sequences essential for translation of a1ACT. These effects on expression were seen to an equivalent degree with both the a1A WT and the human a1A subunit cDNA bearing the pathological polyQ tract (Q33, a1A SCA6 ).
CACNA1A mRNA Contains an Internal Ribosome Entry Site
We hypothesized that expression of a1ACT fragment may be mediated by an IRES present within the CACNA1A coding sequence. Two-dimensional structure analyses of the complete a1A mRNA sequence using an M-fold-based algorithm (Palmenberg and Sgro, 1997; Zuker, 2003) did not identify any canonical type I or type II IRES structures in this region (Baird et al., 2006) . However, the region containing nucleotides 5,096-6,110 was predicted to form a highly complex, stable conformation possessing several stem-loop structures that could represent an area of functional significance for ribosomal binding and interaction with trans-activating factors ( Figure S2 ). This region is highly conserved, from 89.4% in Bos taurus to 76.7% in Danio rerio (data not shown).
To test for IRES activity within this region, we inserted DNA segments of different lengths (Figure 2 ) from the region 5 0 to the a1ACT start site into the bicistronic (Renilla luciferase, R-Luc, and firefly luciferase, F-Luc) reporter vector, pRF (Figure 2A) (Spriggs et al., 2009) . Because the coding region for the R-Luc is followed by a stop codon, an increase in F-Luc activity indicates the presence of an upstream IRES that enables rebinding of the dual luciferase transcript to the ribosomal machinery. Expression of pRCT653TF or pRCT1014TF, but not pRCT189TF and pRCT293TF, in HEK293 cells enhanced the activity of the F-Luc approximately 9-and 26-fold (Figures 2A  and 2B ). Moreover, insertion of 1 or 2 nucleotides immediately 5 0 to the ATG codon prior to the F-Luc coding region within the pRF vector eliminated the accumulation of F-Luc ( Figures 2C  and 2D ). Therefore, the structure of the CACNA1A IRES is highly dependent on initiating translation of the second cistron at a specific codon, ATG 1960, as is typical of most IRES activation (Fitzgerald and Semler, 2009; Wilson et al., 2000) . To help exclude the possibility that the increased F-Luc activity was due to a change at the RNA level, we inserted the same segments into the promoterless reporter vector, pGL3Basic. Transfection into HEK293 cells yielded no significant increase of luciferase activity ( Figures 2E-2G ), arguing against the presence of a cryptic promoter in these segments. Subsequently, we performed quantitative real-time PCR on two amplicons within the Renilla open reading frame (ORF) and one near the initiation codon of firefly ORF ( Figure 2A ). The observed ratio of 1:1 Renilla:Firefly mRNA ( Figure 2H ) favors the presence of an IRES, rather than increased transcription of the second reporter via a cryptic promoter, a splicing event or any other increase in mRNA stability. In addition, the quantitative realtime PCR expression ratios for gene fragments (5 0 to or 3 0 to the a1ACT start site) within the a1A subunit were approximately one in untransfected HEK293 or PC12 cells. Lastly, we found equivalent signals from before and after the a1ACT start site using endogenous a1A mRNA isolated from human cerebellum ( Figures 2I and 2J ). These results suggest that expression of a1ACT is driven by the presence of a cellular IRES within the a1A coding region rather than by a cryptic promoter or splicing event.
The Translocated a1ACT Fragment Binds to Noncoding Regions of Genes Expressed in Purkinje Cells and Activates Transcription Earlier studies indicated that the 75 kDa a1ACT, bearing the normal polyQ tract, was enriched in the nucleus (Ishiguro et al., 2010; Kordasiewicz et al., 2006) . To investigate whether a1ACT WT (Q11) plays a role in gene expression by binding to genomic DNA, we performed chromatin immunoprecipitationbased cloning (ChIP-based cloning) from PC12 cells transfected with a1ACT-FLAG fusion protein (Experimental Procedures). Potential target genes identified via ChIP-based cloning and sequencing include granulin (GRN), B cell translation gene 1 (BTG1), Ca 2+ ATPase, plasma membrane 2 (PMCA2), integrin a-8 precursor (ITGA8), and TATA box binding protein-associated factor of RNA pol II (TAF1) ( Table S2 ). Putative interaction between a1ACT-FLAG fusion protein and cloned DNA segments within the BTG1, PMCA2, and GRN genes was further confirmed by ChIP quantitative real-time PCR (Figures 3A and 3B ). Although these genes are not uniquely expressed in PCs, the (legend continued on next page) abundant expression of a1ACT in PCs suggests that they are part of a PC-specific developmental program.
We tested whether a1ACT regulates gene expression through the target sequences identified in ChIP-based cloning. Within the BTG1 3 0 UTR, we identified an enhancer within the 113 bp sequence that was obtained from a1ACT ChIP-based cloning, using reporter assays with segments spanning three lengths (beginning at 517 nt) from the 3 0 UTR inserted into the pGL3 promoter vector (Du et al., 2009) , as shown in Figure 3C . Importantly, overexpression of a1ACT WT significantly increased luciferase activity in the BTG1-630 reporter construct, suggesting that BTG1 3 0 UTR contains an a1ACT-regulated enhancer element. However, a1ACT SCA6 , bearing the pathological polyQ tract (Q33) failed to increase BTG1 3 0 UTR-enhanced luciferase expression ( Figure 3C ). We obtained similar results from two segments of 5 0 flanking region in the progranulin gene using the pGL3-basic vector. The a1ACT WT fragment, but not the a1ACT SCA6 fragment, increased expression of the reporters bearing the 1,662 bp fragment by 2-fold and the 638 bp fragment by 3.2-fold ( Figure 3D ). Thus, a1ACT WT has direct gene regulatory effects on at least two target genes, and these are lacking with a1ACT SCA6 .
AT-Rich Element of a1ACT Binding Site Is Essential for the BTG1 Enhancer Activity Alignments of ChIP-identified sequences predict two distinct motifs, (1) an AT-rich element, TTATAAAA, and (2) a CA-rich element, CCAA, as potential a1ACT binding sites ( Figure 3E ). The 113 bp BTG1 3 0 UTR sequence (517-630 bps BTG1 wildtype [WT]; Table S3 ) contains both consensus sequences. As shown in Figure 3F by electrophoretic mobility shift assays (EMSA) using the BTG1 WT as probe and nuclear extracts from untreated PC12 cells or from those transfected with a1ACT WT and a1ACT SCA6 , we observed a component in PC12 cells, caused a significant gel shift (complexes I, II, and III). This indicates that the BTG1 3 0 UTR contains cis-elements reacting with neuron-specific nuclear protein, present in both untransfected and a1ACT-transfected cells. The three protein complexes with the BTG1 WT probe could be abolished by an excess unlabeled BTG1 WT probe, indicating that the binding was specific (lanes 3 and 4, Figure 3F ). Interestingly, nuclear extracts from a1ACT SCA6 -transfected PC12 cells (lane 8, Figure 3F) led to a different migration and pattern of DNA-protein complexes compared to a1ACT WT -expressing cells (lane 5, Figure 3F) , with a greater abundance of complex IV in complexes from the a1ACT SCA6 -transfected PC12 cells. This suggests that a1ACT SCA6 has a different protein binding pattern from a1ACT WT .
To further identify a1ACT consensus sequences, we used the AT-rich consensus element as a probe in EMSA (Table S3 ; Figure 3G) . The AT-rich consensus sequence greatly reduced the formation of the complexes (lane 7, Figure 3G ), whereas mutant AT-rich elements only partially reduced the complex formation (lanes 5 and 6, Figure 3G ). Anti-FLAG antibodies generated a super-shifted complex with nuclear extracts from a1ACT WT -FLAG-expressing cells (lanes 8 and 9, Figure 3G ). These studies demonstrate that a1ACT binds to an AT-rich element in the BTG1 3 0 UTR. Finally, we performed EMSA with a series of 3 bp mutations of the TTATAAGAT sequence (Table S3) . As shown in Figure 3H , Mut1 abolished complex II and Mut2 abolished complex I. Mut4, combining Mut1 and Mut2, abolished both complexes I and II ( Figure S3 ). We also mutated the element, TTATAAGT, within the BTG1-630 reporter construct (517-630 bp). Constructs 630mut1 and 630mut2 contain 3 bp mutation, whereas 630mut4 contains both Mut1 and Mut2 substitutions. All three constructs had significantly reduced luciferase activities, both basally and in response to overexpressing of a1ACT WT compared to BTG1 630 construct ( Figure 3I ). These results suggest that TTATAA is the core sequence of the AT-rich element that is required to maintain the a1ACT-regulated BTG1 expression.
The a1ACT WT , but Not a1ACT SCA6 , Increases the Physiological Expression of Target Genes and Enhances Neurite Outgrowth of Differentiating PC12 Cells To test for an effect of a1ACT on endogenous expression of ChIP-identified genes, we examined the mRNA and protein levels of TAF, BTG1, PMCA2, and GRN in both cell lines and human cerebellum. Overexpression of normal a1A WT or a1ACT WT , but not a1ACT SCA6 , significantly increased the expression of these genes (1.6-to 2.7-fold) in PC12 cells, either compared to empty vector-transfected or a1ACT SCA6 -transfected PC12 cells ( Figure 4A ). As shown in Figures 4B and 4C, BTG1 and PMCA2 protein expression levels were also increased in a1A WT -and a1ACT WT -transfected PC12 cells. Finally, using cerebellar tissues from two SCA6 patients (Q22) and normalizing transcript levels to a PC-specific mRNA, Pcp2, we found that BTG1 gene mRNA expression was decreased compared to the normal control ( Figure 4D) .
Several of the genes regulated by a1ACT are known to play a role in differentiation of the neuronal phenotype (Baker et al., 2006) . We established PC12 cell lines stably expressing 3xFLAG-tagged versions of either the full-length a1A or the a1ACT fragment. Upon induction with nerve growth factor (NGF) for 24 hr, we observed that both a1A WT -FLAG and a1ACT WT -FLAG enhanced neurite outgrowth (fraction of cells with neurites) when compared with PC12 cells expressing empty vector (Figures 4E-4H ; Figures S4A-S4D) . Importantly, the P/Q channel blocker, u-agatoxin, had no effect on a1ACT WT -induced neurite outgrowth ( Figure S4E ). Furthermore, blocking the expression of endogenous or transfected full-length a1A by small interference RNA (siRNA) had no effect on a1ACT WTenhanced neurite outgrowth in PC12 cells transfected with a1ACT WT -FLAG ( Figures S4E-S4K ). These findings suggest that enhanced neurite outgrowth does not depend on functioning channels or the presence of the full channel protein.
(H) Deletion of a 534 bp fragment (a1Adel534Q11), but not deletion of a 185 bp fragment (a1Adel185Q11), from the a1A coding region upstream of the a1ACT eliminates a1ACT expression, while maintaining expression of full-length a1A-FLAG. Deletions using encoded Q33 repeat expansions constructs (a1Adel185Q33 and a1Adel534Q33) behave similar to the Q11 constructs. See also Figure S1 . 
(legend continued on next page)
There was a significant increase in the percentage of cells bearing neurites in cells transfected with a1A WT -FLAG and a1ACT WT -FLAG compared to controls after NGF stimulation for 24, 48, and 72 hr ( Figures 4E, 4F , and 4H). Total neurite lengths were also increased 2-fold in a1ACT WT -expressing cells compared with controls at each time point ( Figure 4G ; Figures  S4A-S4D) . However, cells expressing a1ACT SCA6 -FLAG had significantly lower percentage of cells with neurites and total neurite length/cell compared with cells expressing a1ACT WT -FLAG (Figures 4E-4H ; Figures S4A-S4D) . Thus, a1ACT SCA6 lacks the normal function of a1ACT WT in potentiating neurite outgrowth in neuronal cells.
BTG1 belongs to the BTG/TOB protein family of antiproliferative genes. Both BTG1 and BTG2 proteins interact with the protein arginine N-methyltransferase (i.e., PRMT1) and positively modulate its activity. The PRMT1/BTG methylation pathway is involved in maintaining neuronal cells in a differentiated state (Berthet et al., 2002) . We used BTG1 antibody to immunoprecipitate PRMT1 in PC12 cells stably transfected with a1ACT WT and a1ACT SCA6 . In a1ACT WT -expressing cells, the quantity of precipitated PRMT1 was increased, whereas in a1ACT SCA6 -expressing cells, precipitated PRMT1 was decreased, consistent with the expression of BTG1 in these two cell types ( Figure 4I ). Meanwhile, silencing of BTG1 by siRNA blocked the NGF-induced a1ACT-regulated neurite outgrowth (Figures 4J-4L ; Figure S4L ). These results demonstrate that a1ACT with normal range polyQ maintains the physiological expression of the BTG1 gene, leading to subsequent interaction of the PRMT1/BTG pathway to mediate neuronal differentiation. Together, these observations suggest that the normal a1ACT acts as a transcription factor through target genes to enhance the neuronal phenotype and that one effect of the SCA6 polyQ expansion in a1ACT is to disrupt the properties of the a1ACT transcription factor.
a1ACT Partially Rescues the Phenotype of a1A À/À Mice a1A À/À mice, with targeted disruption of mouse CACNA1A, develop a gross neurological phenotype of seizures, dystonia, and ataxia soon after birth and die by P18-P21 (Jun et al., 1999) . To investigate the importance of expression of the a1ACT fragment in PCs, we used the Pcp2 promoter and Tet-off system (Zu et al., 2004) to generate two double transgenic mouse lines, Pcp2-tTA/TRE-a1ACT (abbreviated, PC-a1ACT), expressing at comparable levels either a1ACT WT (WT = Q4, the smallest a1ACT polyQ seen in humans) or a1ACT SCA6 (SCA6 = Q33, the largest a1ACT polyQ seen in SCA6) fragments tagged with an N-terminal myc epitope (see Experimental Procedures). These mice appeared to grow and develop normally and live a full lifespan. a1ACT SCA6 mice, however, had mild progressive motor problems that were evident using the treadmill (see below).
To test the role of a1ACT in cerebellar PC development in the absence of a1A channels, we bred PC-a1ACT mice with a1A +/À heterozygous knockout mice and subsequently crossed these offspring to generate a1A À/À mice with PC-targeted a1ACT expression (a1A À/À /PC-a1ACT). Curiously, we did not identify any mice with a1A
À/À /PC-a1ACT SCA6 genotype, suggesting an impaired viability ( Figure 5A ). As expected, a1A À/À exhibited severe neurological impairment (Jun et al., 1999) . Surprisingly, a1A À/À mice expressing a1ACT WT , i.e., a1A À/À /PC-a1ACT WT mice, had an improved behavioral phenotype relative to a1A À/À mice. Although still neurologically impaired, they gained more weight during the first 2 weeks of postnatal life compared to a1A À/À mice ( Figures 5B and 5C ), had improved in-cage mobility (Movie S1), and survived $1 week longer than a1A À/À mice ( Figure 5D ). We reasoned that the improved phenotype of a1A
/PC-a1ACT WT mouse might be mediated through improved dendritic and synaptic development. Immunofluorescent staining of cerebellar cortex of P16 mice from three groups, WT, a1A
, and a1A À/À /PC-a1ACT WT mice showed that, as noted previously, PCs of a1A À/À mice had shortened primary dendrites with premature branching and an immature pattern of parallel fiber (PF) and climbing fiber (CF) synaptic contacts on PC soma and proximal dendrites (Hashimoto et al., 2011) ( Figures 5E-5L ). In contrast, PC morphology and afferent innervation of a1A À/À /PC-a1ACT WT cells resembled the pattern in WT mice ( Figures 5E-5L ). In a1A
/PC-a1ACT WT mice, the thickness of molecular layer (ML), the relative height, and density of the dendritic tree were significantly increased, compared to those of a1A À/À mice (p < 0.05) (Figures 5F-5H ). This finding is consistent with our in vitro studies showing that a1ACT enhances neurite outgrowth.
We also compared the height of CF innervation between the three mouse groups ( Figures 5J-5L ) (Hashimoto and Kano, 2005; Hashimoto et al., 2011) . In a1A À/À mice, most PCs were multi-innervated, and the CF height only reached 65.2% ± 5.3% of the ML at P16. We found that the CF height was improved in a1A À/À /PC-a1ACT WT mice over that of a1A À/À mice, reaching to 80.7% ± 4.1% of the ML at P16 (p < 0.05). However, a1A
À/À /PC-a1ACT WT mice exhibited the same three patterns of CF contacts seen with a1A À/À mice, mono CF on PC dendrites, multiple CF contacts on proximal dendrites, and multiple CF contacts on PC soma ( Figure 5 ). These results demonstrate that a1ACT, as a transcription factor, plays an important role in establishing normal dendritic tree morphology in PCs in vivo but that synapse elimination or selection of dominant innervation requires either P/Q channel function or a1ACT under its endogenous expression pattern. Finally, we examined mRNA levels of TAF, BTG1, PMCA2, and GRN in the three mouse groups. Figure S5 demonstrates that the expression of these genes was decreased in cerebellar tissue of a1A À/À mice when compared to normal mice but was increased 1.5-to 3-fold in a1A
À/À /PC-a1ACT WT transgenic mice when compared to a1A À/À mice (p < 0.05), relative to either b-actin (H) Quantitative real-time PCR performed using RNA from cells transfected with bicistronic vectors as amplified using primers Ren1, Ren2, and Fire demonstrates no difference in abundance of R-Luc and F-Luc mRNA.
(I and J) Quantitative real-time PCR performed using RNA extracted from PC12 and HEK293 cells, transfected with a1A or human cerebellum to compare abundance of amplicons Ex34-35, Ex38-39, and Ex39-40 upstream of the a1ACT start site relative to amplicons Ex41-42 (I) and Ex41-43 (J), from within the a1ACT coding region. Data are mean ± SEM, n R 3 (each involving triplicate assays, *p < 0.05, **p < 0.01). See also Figure S2 .
or Pcp2 gene expression ( Figures S5A-S5D ). These results indicate that expression of the a1ACT target genes is impaired in a1A À/À mice and is corrected by localized expression of a1ACT WT in PCs of transgenic mice.
a1ACT Partially Restores Parallel Fiber EPSC Amplitude, but Not Climbing Fiber Monoinnervation To further assess the effect of a1ACT expression on Purkinje cell synaptic properties, we measured PF excitatory postsynaptic current (PF-EPSC) amplitude as a function of stimulus intensity in WT, a1A À/À , and a1A
À/À /PC-a1ACT WT mice (P16-P18) in cerebellar slice preparations. Whereas PF-EPSCs from WT were significantly larger than those from both a1A À/À mice (p < 0.01, stimulus intensities 20-55 mA) and a1A À/À /PCa1ACT WT mice (p < 0.05), EPSCs from a1A À/À /PC-a1ACT WT mice were greater than those from a1A À/À mice (p < 0.05),
indicating that a1ACT expression improves PF synaptic connections ( Figure 6A ). The inability of a1ACT to completely restore EPSC amplitudes to WT levels could be explained by the absence of P/Q-type Ca 2+ channels in PF presynaptic terminals of a1A À/À /PC-a1ACT WT mice, as these channels play a critical role in neurotransmitter release at PF-Purkinje cell (PF-PC) synapses (Matsushita et al., 2002; Mintz et al., 1995) . We therefore examined the presynaptic release properties of PF-PC synapses in a1A À/À and a1A
/PCa1ACT WT mice by measuring the paired-pulse ratios (PPRs) of PF-EPSCs. Large PPRs are indicative of low initial release probabilities and are a sign of impaired presynaptic function (Zucker and Regehr, 2002) . In accordance with observations from mouse models harboring loss-of-function mutations in the CACNA1A gene, a1A À/À mice exhibited PPRs significantly greater than WT at several stimulus intervals (WT to a1A À/À mice: p < 0.01 for stimulus intervals of 20-100 ms, Figure 6B ) (Liu and Friel, 2008; Matsushita et al., 2002) . Whereas a1ACT expression did lower PPRs closer to WT levels (a1A
/PC-a1ACT WT to a1A À/À mice: p < 0.01 for stimulus intervals of 20 and 100 ms, p < 0.05 for stimulus interval of 50 ms), the measured values were still elevated (WT to a1A À/À /PC-a1ACT WT : p < 0.05 for stimulus intervals of 20 and 50 ms) ( Figure 6B ), suggesting a residual presynaptic deficit.
We also examined properties of the CF synapse onto Purkinje cells. We observed a reduction in CF EPSC amplitudes and a decrease in the degree of paired-pulse depression in both a1A À/À and a1A À/À /PC-a1ACT WT mice with respect to WT, both of which could also be due to the absence of P/Q-type channels presynaptically ( Figure 6C ). Additionally, we investigated whether a1ACT expression affects the process of CF maturation. During development, Purkinje cells undergo a competitive and activity-dependent elimination of superfluous CF inputs until only one remains. Impairments to this process result in the persistent innervation of Purkinje cells by multiple climbing fibers into adulthood. We found the proportion of Purkinje cells with multiple CF innervations to be increased in both a1A
À/À and a1A À/À /PC-a1ACT WT mice compared to WT, a result indicating that actual P/Q-type Ca 2+ channel function,
and not just expression of the C terminus, may be essential for proper CF maturation (Watanabe and Kano, 2011) ( Figure 6D ). Our results provide evidence that a1ACT expression improves the synaptic connections of PFs, but not CFs, onto Purkinje cells.
a1ACT SCA6 Causes Cell Death In Vitro and Mediates Ataxia and Cerebellar Cortical Atrophy in Transgenic Mice
Previous studies have shown that the a1A C terminus bearing an expanded polyQ tract is toxic relative to WT a1A C terminus when transiently overexpressed in cultured mammalian cells (Ishiguro et al., 2010; Kubodera et al., 2003) . Our flow cytometry results showed that PC12 cells stably expressing a1ACT WT exhibited equivalent viability to vector control cells, whereas cells expressing a1ACT SCA6 had an $2-fold increase in cell death (p < 0.05, Figure 7A -7C) (Koopman et al., 1994) . Also, lactate dehydrogenase (LDH) release was significantly higher in cells expressing the a1ACT SCA6 compared with that of PC12 cells expressing only pcDNA3 or a1ACT WT ( Figure 7D ). These findings indicate that overexpression of a1ACT bearing pathological size of polyQ reduces cell viability in cultured mammalian cells. Finally, we tested whether overexpression of the SCA6-expanded a1ACT SCA6 fragment in mice would lead to clinical or pathological features resembling SCA6, compared with overexpression of the fragment with normal allele size, a1ACT WT . Both a1ACT WT and a1ACT SCA6 can be detected in the nucleus of PCs in the corresponding PC-a1ACT lines at comparable levels by western blot, quantitative real-time PCR, and immunostaining ( Figure 7E ; Figures S6A and S6B ). There were no obvious clinical differences between these two lines in young adults, and lifespan was not affected. However, we found that PC-a1ACT SCA6 mice demonstrated significant abnormalities in several gait parameters compared with PC-a1ACT WT mice using a video-assisted computerized treadmill for gait analysis (DigiGait, Mouse Specifics) (p < 0.05, after post hoc correction). Most importantly, they exhibited an age-dependent increase in shared stance (double support time) of hind limbs, between 3 and 9 months old, indicating progressive instability during walking (p < 0.05, Figure 7F ; Movies S2 and S3) (Matsukawa et al., 2003; Stolze et al., 2002) . The gait disturbance never progressed to the level of severe ataxia, although natural changes in weight gain in older mice may have obscured an impact on normal cage activity. The lack of severe ataxia even in 2-year-old mice is not surprising for a model of SCA6, with an age of onset of 43-52 years. Although we found no obvious sign of cell loss in the cerebellum in a1ACT SCA6 mice at $2 years of age, measurement of the ML thickness showed that a1ACT SCA6 -expressing mice have significant thinning of the ML, compared with age-matched a1ACT WT and WT mice ( Figures 7G and 7H) . Lastly, using quantitative realtime PCR to examine the expression levels of ChIP-identified genes TAF, GRN, BTG1, and PMCA2 in cerebellar tissues of 2-year-old PC-a1ACT SCA6 mice compared with age-matched WT mice, we found that the transcript levels of each of the a1ACT-regulated genes were decreased by between 11% and 34% ( Figures S6C-S6F ). These findings are the first to demonstrate clinical and pathological changes in an animal model of SCA6 expressing appropriate-sized pathological alleles within a CACNA1A-encoded protein.
DISCUSSION
CACNA1A Contains a Cellular IRES Cellular IRESs play an increasingly recognized role in the control of eukaryote gene expression, where in many 5 0 UTRs they provide alternatives to cap-dependent translation initiation during times of cellular stress (Coldwell et al., 2001; Spriggs et al., 2008) . IRES sequences have also been detected within the coding regions of some cellular mRNAs, leading to the expression of isoforms or distinct protein products (Cornelis et al., 2000; Ul-Hussain et al., 2008) . Together with the present report, these observations suggest that expression of bifunctional genes, particularly those encoding separate transcription factor proteins in the second cistron, may be a strategy for coordinating gene expression programs tied to individual gene products. This could enable the timely expression of a set of genes coincident with the appearance of key proteins during differentiation.
a1ACT, a CACNA1A-Encoded Transcription Factor, Promotes a Neurite Outgrowth Program As a transcription factor, the normal a1ACT enhances the expression of at least three genes, GRN, PMCA2, and BTG1, in PC12 cells and cerebellar tissue, potentiates NGF-mediated neurite outgrowth in PC12 cells, and partially rescues the CACNA1A knockout phenotype. GRN is involved in neurite outgrowth and is critical in maintaining neuronal survival because loss-of-function mutations of the GRN gene lead to cell death in the frontal and temporal lobes (Baker et al., 2006; Cruts et al., 2006; Van Damme et al., 2008) . PMCA2 is highly expressed in the cerebellum, particularly in PCs and throughout the ML and granule cell layer (Zacharias and Kappen, 1999) . PMCA2 knockout mice exhibit vestibular and gait abnormalities and reduced thickness of the cerebellar ML (Kozel et al., 1998) . Lack of PMCA2 also dramatically alters PC morphology. PMCA2 is a component of mGluR1-IP3R1 signaling complex, which has been implicated in plasticity at the PF-PC synapse (Kurnellas et al., 2007) .
The PRMT1/BTG methylation pathway is involved in neurogenesis or in maintaining neuronal cells in a differentiated state. The 3 0 UTR of BTG1 is highly conserved throughout evolution and plays a key role in this pathway (Rouault et al., 1993) , consistent with our finding that a1ACT activates a novel 3 0 enhancer element of BTG1. Enhanced BTG1/PRMT1-driven arginine methylation partly accounts for the essential role of protein methylation during PC12 differentiation (Cimato et al., 1997) , which is in line with findings here that BTG1 knockdown blocks neurite outgrowth. Together, these findings suggest that a1ACT WT is essential for maintenance of neurite outgrowth through gene-specific signaling pathways. It will be of interest to extend our ChIP-based cloning approach using RNA-seq methodology to more completely characterize the normal repertoire of a1ACT-regulated genes, as well as those bound by a1ACT SCA6 .
Except for the in vivo studies, the properties of a1ACT are similar to those demonstrated for the 70 kDa fragment, termed CCAT, derived from the Cav1.2 channel, a1C subunit, which may arise from a similar translational mechanism (Gomez-Ospina et al., 2006) . In that case, as well as in ours, the set of genes regulated by these transcription factors does not conform to an obvious functional class of proteins but appears to be involved in elaborating key components of the neuronal phenotype and in neurogenesis or neurodegeneration, timed with the appearance of Ca 2+ channel activity.
The improved phenotype at behavioral, histological, and electrophysiological levels in a1A
/PC-a1ACT WT mice is remarkable, particularly because a1ACT WT expression, under the control of PC specific promoter, Pcp2, was only restored in PCs. Consistent with these findings and our in vitro results, ChIP-identified genes TAF, BTG1, PMCA2, and GRN were downregulated in a1A À/À mice but were increased 1.5-to 3-fold in a1A
À/À /PCa1ACT WT transgenic mice. These results suggest that a1ACT, as a second gene product from CACNA1A, plays an important role in establishing normal morphology and function of PCs.
a1ACT Expression Improves PF-PC Connections PF-EPSC amplitudes measured in a1A À/À /PC-a1ACT WT were significantly greater than those observed in a1A À/À mice, though they were not completely restored to WT levels, presumably due (legend continued on next page)
to the importance of P/Q-type Ca 2+ channel function to neurotransmitter release at PF-PC synapses (Mintz et al., 1995) . a1ACT expression also resulted in a partial reduction of PPRs at this synapse, which was surprising as PPRs generally reflect presynaptic release probabilities, and a1ACT is present only postsynaptically in a1A /PC-a1ACT WT mice was significantly improved compared to a1A À/À (*p < 0.05). Some pups survived until age of P30 (n = 2, not included in the figure) , whereas all a1A À/À pups died before P20.
(E-H) a1ACT expression improves cerebellar cortex and PC dendrites. Low power images of cerebellar ML (E). PC dendrites are labeled for calbindin-28 kDa (green). The thickness of the ML (F), the relative height of dendritic tree (G), and the density (as defined in the Experimental Procedures) of the PC dendritic tree (H) were reduced in a1A À/À mice and partially corrected in a1A
/PC-a1ACT WT mice (100 dendritic trees from five mice at each group. Control is set as one, *p < 0.05). (I) Immunolabeling of PFs and PC dendrites using anti-vGlut1 (red) and anti-calbindin (green) antibodies. (J) Immunolabeling of CFs and PC dendrites using anti-vGlut2 (red) and anti-calbindin (green) antibodies. (K and L) Quantitation of CF reach (K) and relative height of dendritic tree (L) (100 CFs, *p < 0.05). CF height was measured from the apical pole of PC somata to the tips of vGluT2-labeled CFs. Data are mean ± SEM. See also Figure S5 . /PC-a1ACT mice exhibiting multiple CF innervation. Right: Percentage of PCs exhibiting one, two, or three discrete CF steps in a1A À/À (two steps: 6/13, three steps: 1/13, n = 3), a1A
À/À /PC-a1ACT (two steps: 5/13, n = 3), and WT (two steps: 1/9, n = 3) mice. All mice were age P16-P18. *p < 0.05, **p < 0.01. Data are mean ± SEM. factors either directly or indirectly related to the postsynaptic target cell can also influence this parameter. Regardless, the residual elevation of PPRs in a1A À/À /PC-a1ACT WT mice suggests that the incomplete restoration of PF-EPSC amplitude is due to a presynaptic deficit in these mice.
The absence of any discernable effect of a1ACT expression on CF-EPSCs indicates that actual P/Q-type Ca 2+ channel function is required for the process of CF maturation, as has been suggested previously . Thus, it appears that the phenotypic benefits of a1ACT expression are due predominantly to the improvement in PF synaptic transmission.
a1ACT SCA6 Abolishes the Normal Function of a1ACT in Gene Expression Regulation and Is Pathogenic In Vitro and In Vivo Compared to the properties of the normal a1ACT protein, a1ACT WT , bearing 4 or 11 glutamines, the a1ACT SCA6 polypeptide had altered binding to the BTG1 enhancer, showing additional DNA-protein complexes, and lacked the capacity to mediate expression via BTG1 and GRN luciferase reporters and impaired expression of these genes in PC12 cells. a1ACT SCA6 also failed to mediate neurite outgrowth when stably expressed in PC12 cells and caused increased cell death. This may explain why we did not obtain any mice with a1A À/À /PCa1ACT SCA6 genotype. Mice overexpressing a1ACT SCA6 on a normal background exhibited subtle but clearly measurable defects in motor functioning. Computerized treadmill gait analysis demonstrated progressive gait impairment with an increase in double limb support, a compensatory reaction to instability during walking. With advanced age, a1ACT SCA6 was associated with thinning of the cerebellar cortex. These mice have reduced levels of expression of TAF1, GRN, BTG1, and PMCA2, the targets of a1ACT, relative to endogenous PC transcripts. These studies suggest that, rather than arising from ion channel dysfunction, the pathogenesis of SCA6 more closely resembles the toxic gain-of-function mechanism of the polyQ disorders (La Spada et al., 1991; Palhan et al., 2005; Sopher et al., 2004) . This is supported by the lack of disturbed Ca 2+ channel function in two mouse knockin studies of the SCA6 mutation (Saegusa et al., 2007; Watase et al., 2008) . If additional studies further support this Ca 2+ channel-independent mechanism, the demonstration of selective translation based on an IRES may pave the way for therapies targeted at suppressing the IRES function. We have shown that the CACNA1A gene is bicistronic, encoding a newly identified transcription factor, a1ACT, involved with neurite outgrowth and PC maturation, within the a1A mRNA.
a1ACT also bears the expanded polyQ tract in SCA6, which interrupts transcription factor function, impairs viability of cultured cells and is pathogenic in transgenic mice. These findings are summarized in the diagram in Figure 7I .
EXPERIMENTAL PROCEDURES Materials and Standard Protocols
Cells, animals/mouse strains, antibodies, plasmids, and other materials are described in the Extended Experimental Procedures. The detailed protocols used for ChIP, ChIP-based cloning, ChIP quantitative real-time PCR, EMSA, luciferase assays, immunoprecipitation, immunohistochemistry, immunoblotting, quantitative real-time PCR, electrophysiology, and LDH assay are outlined in the Extended Experimental Procedures. This study involves specimens from human subjects and was approved by the Institutional Review Board of the University of Chicago Medical Center. All animal experiments were approved and carried out in accordance with the regulations and guidelines for the care and use of experimental animals at the Institutional Animal Care and Use Committee of the University of Chicago.
Protein Purification and Mass Spectrometry
Protein extracts from HEK293 cells stably transfected with a1A subunit bearing a Q11 allele were separated via anion exchange chromatography (HisTrap FF column) and further purified by ANTI-FLAG M2 affinity purification. a1ACT WT fragment protein in SDS-PAGE gel was digested in-gel with trypsin, and the resulting peptides were then analyzed via LC-MS/MS on an LTQVelos-Orbitrap mass spectrometer. See details in the Extended Experimental Procedures.
Immunohistochemistry and Microscopy
Detailed procedures of immunohistochemistry, antibodies, and dilutions are described in the Extended Experimental Procedures. PC12 cells were imaged 0, 24, 48, and 72 hr after NGF 24 hr treatment. Neurites were defined as processes longer than the width of the cell body. For each experiment, cells were imaged. Dendrites were analyzed by employing ImageJ and NeuroJ programs.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six figures, four tables, and three movies and can be found with this article online at http://dx.doi.org/10.1016/j.cell.2013.05.059.
ACKNOWLEDGMENTS
We thank Professors Sangram S. Sisodia, Brian Popko, and Bert L. Semler for helpful comments on the manuscript, Dr. Raymond Roos for helpful discussions, Dr. Xiaorong Zhu for protein purification technical assistance, Dr. Jeremy Marks and Dr. Janice Wang for rat granule cell cultures and transfection, Dr. Yuanxin Hu for assembling the vectors for PC-a1ACT WT and PCa1ACT SCA6 mice and performing pilot immunoblot and immunohistochemical studies, Devon Collins and Kareisha Robinson for technical support in mouse breeding, genotyping, and DigiGait testing, and Tom Hampton for DigiGait Figure S6 .
